Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Saraswanti Anugerah Makmur Tbk. (SAMF) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Saraswanti Anugerah Makmur Tbk.Trade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Saraswanti Anugerah Makmur Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Saraswanti Anugerah Makmur Tbk. trades at Rp284 (market cap 2.89T, 66.7K 24h volume). The key difference: Saraswanti Anugerah Makmur Tbk. is far larger — about 9.1× Diagnos Laboratorium Utama Tbk.'s market cap, and Saraswanti Anugerah Makmur Tbk. is more actively traded (66.7K versus 41.7K). Which is the better fit depends on your goals.

DGNSSAMF
Market Cap
316.25B2.89T
Volume
41.7K66.7K
Lot
417667
Turnover
9.66M18.79M
Average Price
231.65281.67
Value
9.66M18.79M
Indicative Equilibrium Price
230
Indicative Equilibrium Volume
2.4K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
SAMF
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Saraswanti Anugerah Makmur Tbk.

PT. Saraswanti Anugerah Makmur Tbk. (the Company) was established based on the Notarial Deed of Titiek Lintang Trenggonowati, S.H., No.15 dated June 18, 1998, notary in Surabaya.

Read more on SAMF